Alpine Immune Sciences Inc.

06/08/2020 | Press release | Distributed by Public on 06/08/2020 06:07

Alpine Immune Sciences Provides Clinical Update of its Phase 1 Trial of ALPN-101 in Healthy Volunteers at the European League Against Rheumatism (EULAR) E-Congress 2020